Skip to content
Screener

AbCellera Biologics Inc. ABCL United States — Total Revenue

Other geography segments

Canada
$36M-92.6%

Similar metrics at other companies

V2X logo
VVXUnited States — Total Revenue
$810.55M+40.4%
Guidewire Software logo
GWREUnited States — Total Revenue
$242.28M+26.4%
GitLab logo
GTLBUnited States — Total Revenue
$217.65M+23.0%
Trimble Inc. logo
TRMBUnited States — Total Revenue
$501.3M+6.7%
Rubrik logo
RBRKUNITED STATES — Total Revenue
$268.2M+37.3%
Elastic logo
ESTCUnited States — Total Revenue
$243.68M+11.8%

Other financials

Income statement

See full
Revenue$4.1M-76.3%
Operating income-$62.8M-26.6%
Net income-$55.4M-59.6%
EPS (diluted)-$0.18-50.0%

Balance sheet

See full
Cash & equivalents$145.1M+23.5%
Total debt$135.6M-4.5%
Total equity$896.0M-11.0%
Total assets$1.3B-6.7%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$2.1M-84.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.99B+62.2%
Enterprise value$1.98B+58.2%
P/S30.1×-7.3×

Profitability

See full
Operating margin-340.3%-127pp
Net margin-248.8%-83.6pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-17.3%+2.1pp
Debt / equity0.2×0.0×
Current ratio12.8×+1.7×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 4:38 PM EST
Fiscal year
FY2025
Accession
0001703057-26-000012

In 2023, $36.0 million and $2.0 million of revenues originated from services performed in Canada and the U.S., respectively, and in 2024, $26.2 million and $2.7 million of revenues originated from services performed in Canada and the U.S., respectively. In 2025, $64.0 million and $11.1 million of revenues originated from services performed in Canada and the U.S., respectively.

Item 16. Form 10-K Summary

FAQ

What is AbCellera Biologics Inc.'s united states — total revenue?
AbCellera Biologics Inc. (ABCL) reported united states — total revenue of $2.78M in Q4 2025.
How has AbCellera Biologics Inc.'s united states — total revenue changed year-over-year?
AbCellera Biologics Inc.'s united states — total revenue increased by 311.1% year-over-year, from $675K to $2.78M.
What is the long-term trend for AbCellera Biologics Inc.'s united states — total revenue?
Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s united states — total revenue has grown at a -15.5% compound annual growth rate (CAGR), from $21.8M to $11.1M.
What does united states — total revenue mean?
This metric represents the total gross income generated from operations within the United States geographic region. It reflects the company's ability to monetize its platform services and partnership agreements specifically within the domestic market. Tracking this figure helps investors assess the geographic concentration of revenue and the success of regional business development efforts.

Ask your AI about AbCellera Biologics Inc.'s united states — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude